1.2900
+0.0500
+(4.03%)
At close: 4:00:00 PM EDT
1.2101
-0.08
(-6.19%)
After hours: 4:55:04 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.92 | -0.49 | -3.46 | 0 |
| Low Estimate | -0.92 | -0.49 | -3.46 | 0 |
| High Estimate | -0.92 | -0.49 | -3.46 | 0 |
| Year Ago EPS | 0.56 | -5.6 | -11.35 | -3.46 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -- | -- | 1M | -- |
| Low Estimate | -- | -- | 1M | -- |
| High Estimate | -- | -- | 1M | -- |
| Year Ago Sales | -- | -- | 18.63k | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 5,267.69% | -- |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -5.6 | -6.12 | -5.52 | -11.12 |
| EPS Actual | 0.56 | -5.6 | -10.39 | -1.56 |
| Difference | 6.16 | 0.52 | -4.87 | 9.56 |
| Surprise % | 110.00% | 8.50% | -88.22% | 85.97% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.92 | -0.49 | -3.46 | 0 |
| 7 Days Ago | -0.92 | -0.49 | -3.46 | 0 |
| 30 Days Ago | -6.32 | -6.32 | -27.36 | 0 |
| 60 Days Ago | -6.32 | -6.32 | -27.36 | 0 |
| 90 Days Ago | -6.32 | -6.32 | -27.36 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SONN | -264.29% | 91.25% | 69.52% | -- |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Maintains | Chardan Capital: Buy to Buy | 4/7/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/28/2025 |
| Maintains | Chardan Capital: Buy to Buy | 12/20/2024 |
| Maintains | Chardan Capital: Buy to Buy | 8/23/2024 |
| Maintains | Chardan Capital: Buy to Buy | 5/28/2024 |
| Maintains | EF Hutton: Buy to Buy | 5/16/2024 |
Related Tickers
PALI Palisade Bio, Inc.
0.6970
+1.87%
KPRX Kiora Pharmaceuticals, Inc.
2.6600
+2.31%
HOTH Hoth Therapeutics, Inc.
0.8008
-0.46%
CERO CERo Therapeutics Holdings, Inc.
0.6999
-9.10%
SPRC SciSparc Ltd.
0.2836
+3.58%
DRMA Dermata Therapeutics, Inc.
0.8080
+3.70%
THAR Tharimmune, Inc.
1.1500
+7.48%
ENSC Ensysce Biosciences, Inc.
2.0300
+7.98%
REVB Revelation Biosciences, Inc.
3.1800
+5.65%
ENVB Enveric Biosciences, Inc.
1.2500
+6.84%